![]() |
Volumn 29, Issue 1, 1986, Pages 84-89
|
(o- and p-Nitrobenzyloxycarbonyl)-5-fluorouracil Derivatives as Potential Conjugated Bioreductive Alkylating Agents
a a b b b b c |
Author keywords
[No Author keywords available]
|
Indexed keywords
5 FLUORO 1 (4 NITROBENZYLOXYCARBONYL)URACIL;
5 FLUORO 3 (4 NITROBENZYLOXYCARBONYL)URACIL;
ANTINEOPLASTIC AGENT;
FLUOROURACIL;
FLUOROURACIL DERIVATIVE;
NEW DRUG;
TEGAFUR;
UNCLASSIFIED DRUG;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ARTICLE;
BLOOD AND HEMOPOIETIC SYSTEM;
CANCER CHEMOTHERAPY;
DOSE RESPONSE;
DRUG ANALYSIS;
DRUG COMPARISON;
DRUG CYTOTOXICITY;
DRUG IDENTIFICATION;
DRUG MECHANISM;
DRUG POTENTIATION;
DRUG RESPONSE;
DRUG SCREENING;
DRUG STABILITY;
DRUG SYNTHESIS;
EMT 6 TUMOR;
HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;
IN VITRO STUDY;
INTOXICATION;
INTRAPERITONEAL DRUG ADMINISTRATION;
LEUKEMIA;
LEUKEMIA P 388;
MOUSE;
NONHUMAN;
NUCLEAR MAGNETIC RESONANCE;
PRIORITY JOURNAL;
SARCOMA;
SARCOMA 180;
THERAPY;
ANIMALS;
CELLS, CULTURED;
CHEMISTRY;
FLUOROURACIL;
LEUKEMIA P388;
MICE;
NEOPLASMS, EXPERIMENTAL;
OXYGEN;
SARCOMA 180;
STRUCTURE-ACTIVITY RELATIONSHIP;
|
EID: 0022617140
PISSN: 00222623
EISSN: 15204804
Source Type: Journal
DOI: 10.1021/jm00151a014 Document Type: Article |
Times cited : (16)
|
References (14)
|